Furthermore, as cholesterol metabolism in the brain to 24-OHC by the action of CYP46A1 represents a unique mechanism to control brain cholesterol homeostasis, CYP46A1 polymorphisms correlate with lower brain cholesterol levels and increased risk of AD (30, 31). The gene discussed is CYP46A1; the disease is Alzheimer disease.